Expression of HLA class I molecules and the transporter associated with antigen processing in hepatocellular carcinoma

Hepatology

Volumn 23, Issue 5, 1996, Pages 1181-1188

  Kurokohchi, Kazutaka ^a   Carrington, Mary ^b   Mann, Dean L ^a   Simonis, Toni B ^c   Alexander Miller, Martha A ^a   Feinstone, Stephen M ^d   Akatsuka, Toshitaka ^d   Berzofsky, Jay A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; FLOW CYTOMETRY; HLA TYPING; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN PROCESSING; TRANSCRIPTION REGULATION;

EID: 0029912909     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v23.pm0008621152     Document Type: Article

References (28)

1. Rosenthal AS. Determinant selection and macrophage function in genetic control of the immune response. Immunol Rev 1978;40:136-152.
2. Schwartz RH. T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Annu Rev Immunol 1985;3:237-261.
3. Townsend A, Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol 1989;7:601-624.
4. Zinkernagel RM, Doherty PC. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv Immunol 1979;27:51-177.
5. Pardoll DM. Tumor antigens: a new look for the 1990s. Nature 1994;369:357-358.
6. Townsend A, Öhlen C, Bastin J, Ljunggren H-G, Foster L, Kärre K. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 1989;340:443-448.
7. Garrido F, Ruiz-Cabello F. MHC expression on human tumors: its relevance for local tumor growth and metastasis. Semin Cancer Biol 1991;2:3-10.
8. Stern PL, Rinke de Wit TF. The role of MHC class I expression in developmental tumours. Semin Cancer Biol 1991;2:11-16.
9. Garrido F, Cabrera T, Concha A, Glew S, Ruiz-Cabello F, Stern PL. Natural history of HLA expression during tumour development. Immunol Today 1993;14:491-499.
10. Parham P. Transporters of delight. Nature 1990;348:674-675.
11. Monaco JJ, Cho S, Attaya M. Transport protein genes in the murine MHC: possible implications for antigen processing. Science 1990;250:1723-1726.
12. Ortmann B, Androlewicz MJ, Cresswell P. MHC class I/b2-microglobulin complexes associate with TAP transporters before peptide binding. Nature 1994;368:864-867.
13. Suh W-K, Cohen-Doyle MF, Fruh K, Wang K, Peterson PA, Williams DB. Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 1994;264:1322-1326.
14. + T cells. Cell 1992;71:1205-1214.
15. 1, and dimethylnitrosamine by a human hepatoma cell line. Mutat Res 1982;94:339-348.
16. Macnab GM, Alexander JJ, Lecatsas G, Bey EM, Urbanowicz JM. Hepatitis B surface antigen produced by a human hepatoma cell line. Br J Cancer 1976;34:509-515.
17. Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB. Con-trolled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 1979;282:615-616.
18. Tokiwa T, Lipsky MM, Smoot DT, Lechner JF. A method for transforming human liver epithelial cells by transfection using a plasmid containing SV40 early region gene. J Tissue Culture Methods 1994;16:57-60.
19. Radka SF, Kostyu DD, Amos DB. A monoclonal antibody directed against the HLA-Bw6 epitope. J Immunol 1989;128:2804-2806.
20. Parham P, Brodsky FM. Partial purification and some properties of BB7.2: a cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum Immunol 1981;3:277-299.
21. Carrington M, Colonna M, Spies T, Stephens JC, Mann DL. Haplotypic variation of the transporter associated with antigen processing (TAP) genes and their extension of HLA class II region haplotypes. Immunogenetics 1993;37:266-273.
22. Bahram S, Arnold D, Bresnahan M, Strominger JL, Spies T. Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region. Proc Nat Acad Sci U S A 1991;88:10094-10098.
23. Loda M, Giangaspero F, Badiali M, Capodieci P, Pession A. p53 gene expression in medulloblastoma by quantitative polymerase chain reaction. Diagn Mol Pathol 1992;1:36-44.
24. Marincola FM, Shamamian P, Alexander RB, Gnarra JR, Turetskaya RL, Nedospasoi SA, Simonis, et al. Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. J Immunol 1994;153:1225-1237.
25. Kaklamanis L, Townsend A, Doussis-Anagnostopoulou IA, Mortensen N, Harris AL, Gatter KG. Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer. Am J Pathol 1994;145:505-509.
26. Cromme FV, Airey J, Heemels M-T, Ploegh HL, Keating PJ, Stern PL, Meijer CJLM, et al. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J Exp Med 1994;179:335-340.
27. Henderson RA, Michel H, Sakaguchi K, Shabanowitz J, Appella E, Hunt DF, Engelhard VH. HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science 1992;255:1264-1266.
28. Marincola FM, Shamamian P, Simonis TB, Abati A, Hackett J, O'Dea T, Fetsch, et al. Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell lines. J Immunother 1994;16:13-23.